Takhzyro® (lanadelumab-flyo)
| Full Name | Takhzyro® (lanadelumab-flyo) |
| Drug | Takhzyro |
| Manufacturer | Takeda Pharmaceuticals U.S.A., Inc. |
| Route of Administration | Subcutaneous |
| Site of Care | Home |
| Approved Indication | Prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 2 years and older |
| Disease | Hereditary Angioedema (HAE) |
| Therapeutic Area | Allergy & Immunology |
| Enrollment Form Link | Takhzyro Enrollment Form |
| Phone Number | 800-356-4252 |
| Fax Number | 847-631-6918 |
| Product Website | takhzyro.com |